Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares Outstanding
Ratios

Enanta Pharmaceuticals (ENTA) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $8.7 million.

  • Enanta Pharmaceuticals' Other Gross PP&E Adjustments rose 24600.16% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 24600.16%. This contributed to the annual value of $8.7 million for FY2025, which is 24600.16% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Other Gross PP&E Adjustments of $8.7 million as of Q3 2025, which was up 24600.16% from $19.6 million recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $19.6 million for Q2 2025, and its period low was -$36.0 million during Q1 2024.
  • Over the past 5 years, Enanta Pharmaceuticals' median Other Gross PP&E Adjustments value was -$7.7 million (recorded in 2021), while the average stood at -$7.4 million.
  • As far as peak fluctuations go, Enanta Pharmaceuticals' Other Gross PP&E Adjustments tumbled by 27701.84% in 2022, and later surged by 24600.16% in 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$19.4 million in 2021, then dropped by 21.32% to -$23.5 million in 2022, then increased by 9.33% to -$21.3 million in 2023, then surged by 176.98% to $16.4 million in 2024, then tumbled by 46.8% to $8.7 million in 2025.
  • Its Other Gross PP&E Adjustments was $8.7 million in Q3 2025, compared to $19.6 million in Q2 2025 and $18.1 million in Q1 2025.